Abstract WE573: Trends in Cardiovascular Disease (CVD) Risk Factors in American Indian Populations: A Phase 7 update from the Strong Heart Family Study (SHFS)

J Jessica Reese (University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States) T Tauqeer Ali L Lyle Best (Missouri Breaks Industries Research, Watford City, North Dakota, United States) S Shelley Cole (Texas Biomedical Research Institute, San Antonio, Texas, United States) K Kateri Daffron (University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States) R Richard Devereux (Weill Cornell Medicine, New York, New York, United States) R Richard Fabsitz (Missouri Breaks Industries Research, Watford City, North Dakota, United States) A Amanda Fretts (University of Washington School of Public Health, Seattle, Washington, United States) P Pravina Kota (University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States) W Weiyi Li E Elsayed Soliman (Wake Forest School of Medicine, Winston-Salem, North Carolina, United States) J Jason Umans (MedStar Health Research Institute, Bethesda, Maryland, United States) H Heather Willmott (University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States) Y Ying Zhang

Abstract

Introduction: CVD is the leading cause of death among American Indians but major CVD risk factors, like hypertension, diabetes, obesity, smoking, and abnormal cholesterol, have not been updated recently. Therefore, we report changes in the prevalence of major CVD risk factors after a median 21.7 (range= 21.0-22.4) years of follow-up. Methods: The SHFS is the longest running, prospective cohort study of CVD in American Indians from Arizona, Oklahoma, and the Dakotas. We included participants from the SHFS, that completed the baseline (2001-2003), first follow-up (2006-2009), and the most recent, Phase 7, examination (2022-2025, n=1,383). We defined hypertension as high blood pressure (systolic ≥140 or diastolic ≥90 mmHg) or taking antihypertensive medication. Diabetes was defined as a measured fasting plasma glucose level ≥126 mg/dL or taking hypoglycemic medication and obesity as a measured body mass index ≥30 kg/m 2 . Current smoking was self-reported through standardized questionnaires. To measure lipids, we drew blood after a 12-hour fast and defined high LDL-C≥100mg/dL and low HDL-C < 40 mg/dL for men, HDL-C < 50 mg/dL for women. We used logistic generalized estimating equations to determine if the prevalence proportion of the CVD risk factors changed overtime, adjusting for age, sex, and center of collection. Results: During Phase 7, the adjusted prevalence proportion of CVD risk factors were hypertension=37%, diabetes=33%, obesity=64%, current smoking=27%, high LDL-C=43%, and low HDL-C=59% (Figure 1). Over a follow-up of 22 years, the prevalence of hypertension increased 6.7%, diabetes increased 16.4%, obesity increased 6.3%, and low HDL-C increased 21.1% (all p<0.01). Current smoking decreased 4.6% (p=0.03) and the prevalence of high LDL did not change. Conclusion: Although these results may only apply to participants who were relatively healthy at baseline, several risk factors appear to be increasing in American Indian populations, at the same time smoking behavior has decreased, and LDL-C has not changed.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (14)

J

Jessica Reese

University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States

T

Tauqeer Ali

L

Lyle Best

Missouri Breaks Industries Research, Watford City, North Dakota, United States

S

Shelley Cole

Texas Biomedical Research Institute, San Antonio, Texas, United States

K

Kateri Daffron

University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States

R

Richard Devereux

Weill Cornell Medicine, New York, New York, United States

R

Richard Fabsitz

Missouri Breaks Industries Research, Watford City, North Dakota, United States

A

Amanda Fretts

University of Washington School of Public Health, Seattle, Washington, United States

P

Pravina Kota

University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States

W

Weiyi Li

E

Elsayed Soliman

Wake Forest School of Medicine, Winston-Salem, North Carolina, United States

J

Jason Umans

MedStar Health Research Institute, Bethesda, Maryland, United States

H

Heather Willmott

University of Oklahoma- HSC, Oklahoma City, Oklahoma, United States

Y

Ying Zhang